DexCom
DXCM
930 hedge funds and large institutions have $49.5B invested in DexCom in 2021 Q4 according to their latest regulatory filings, with 197 funds opening new positions, 343 increasing their positions, 271 reducing their positions, and 52 closing their positions.
279% more first-time investments, than exits
New positions opened: 197 | Existing positions closed: 52
27% more repeat investments, than reductions
Existing positions increased: 343 | Existing positions reduced: 271
17% more funds holding
Funds holding: 795 → 930 (+135)
3% less capital invested
Capital invested by funds: $51.1B → $49.5B (-$1.57B)
9% less call options, than puts
Call options by funds: $987M | Put options by funds: $1.09B
6.21% less ownership
Funds ownership: 387.53% → 381.32% (-6.2%)
13% less funds holding in top 10
Funds holding in top 10: 15 → 13 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$486M |
| 2 |
BlackRock
New York
|
+$288M |
| 3 |
Two Sigma Advisers
New York
|
+$250M |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$242M |
| 5 |
Two Sigma Investments
New York
|
+$201M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$788M |
| 2 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$483M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
-$459M |
| 4 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$417M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$332M |
DXCM Hedge Fund Activity: Q4 2021 in Review
930 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q4 2021, worth a combined $49.5B — down 3.1% from $51.1B a quarter earlier.
Buyers outnumbered sellers: 197 funds opened new DXCM positions and 52 closed out — a net gain of 145 holders — while 343 added to existing stakes and 271 trimmed.
The largest buyer was Capital Research Global Investors, adding an estimated $486M. The largest seller was Lone Pine Capital, exiting entirely with an estimated $788M sold.
- 930 institutional investors held DexCom (DXCM) as of Q4 2021, up from 795 in Q3 2021.
- Funds reported $49.5B of DexCom stock for Q4 2021, down 3.1% quarter-over-quarter.
- 197 funds opened new DexCom positions in Q4 2021 and 52 closed out, a net change of +145 holders.
- The largest DexCom buyer in Q4 2021 was Capital Research Global Investors, an estimated $486M added.
- The largest DexCom seller in Q4 2021 was Lone Pine Capital, an estimated $788M sold.
Based on aggregated 13F filings for Q4 2021.